These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23834240)

  • 1. Structure-activity relationships in non-ligand binding pocket (non-LBP) diarylhydrazide antiandrogens.
    Caboni L; Egan B; Kelly B; Blanco F; Fayne D; Meegan MJ; Lloyd DG
    J Chem Inf Model; 2013 Aug; 53(8):2116-30. PubMed ID: 23834240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular topology applied to the discovery of 1-benzyl-2-(3-fluorophenyl)-4-hydroxy-3-(3-phenylpropanoyl)-2H-pyrrole-5-one as a non-ligand-binding-pocket antiandrogen.
    Caboni L; Gálvez-Llompart M; Gálvez J; Blanco F; Rubio-Martinez J; Fayne D; Lloyd DG
    J Chem Inf Model; 2014 Oct; 54(10):2953-66. PubMed ID: 25233256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "True" antiandrogens-selective non-ligand-binding pocket disruptors of androgen receptor-coactivator interactions: novel tools for prostate cancer.
    Caboni L; Kinsella GK; Blanco F; Fayne D; Jagoe WN; Carr M; Williams DC; Meegan MJ; Lloyd DG
    J Med Chem; 2012 Feb; 55(4):1635-44. PubMed ID: 22280402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of the T877A mutation on ligand-induced helix-12 positioning of the androgen receptor resulted in design and synthesis of novel antiandrogens.
    Zhou J; Liu B; Geng G; Wu JH
    Proteins; 2010 Feb; 78(3):623-37. PubMed ID: 19787772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of E/Z isomerization in a series of novel non-ligand binding pocket androgen receptor antagonists.
    Blanco F; Egan B; Caboni L; Elguero J; O'Brien J; McCabe T; Fayne D; Meegan MJ; Lloyd DG
    J Chem Inf Model; 2012 Sep; 52(9):2387-97. PubMed ID: 22853713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
    Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
    Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
    Zhou J; Geng G; Shi Q; Sauriol F; Wu JH
    J Med Chem; 2009 Sep; 52(17):5546-50. PubMed ID: 19725582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico investigations of anti-androgen activity of polychlorinated biphenyls.
    Li X; Ye L; Wang X; Shi W; Liu H; Qian X; Zhu Y; Yu H
    Chemosphere; 2013 Aug; 92(7):795-802. PubMed ID: 23664479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Ligand/Structure-Based Virtual Screening and Molecular Dynamics Simulations of Steroidal Androgen Receptor Antagonists.
    Wang Y; Han R; Zhang H; Liu H; Li J; Liu H; Gramatica P
    Biomed Res Int; 2017; 2017():3572394. PubMed ID: 28293633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
    Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
    J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1.
    Nurminen EM; Pihlavisto M; Lázár L; Szakonyi Z; Pentikäinen U; Fülöp F; Pentikäinen OT
    J Med Chem; 2010 Sep; 53(17):6301-15. PubMed ID: 20690686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.
    Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK
    J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer.
    Yoshino H; Sato H; Shiraishi T; Tachibana K; Emura T; Honma A; Ishikura N; Tsunenari T; Watanabe M; Nishimoto A; Nakamura R; Nakagawa T; Ohta M; Takata N; Furumoto K; Kimura K; Kawata H
    Bioorg Med Chem; 2010 Dec; 18(23):8150-7. PubMed ID: 21050768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.
    Duke CB; Jones A; Bohl CE; Dalton JT; Miller DD
    J Med Chem; 2011 Jun; 54(11):3973-6. PubMed ID: 21506597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
    Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
    J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain.
    Xu X; Yang W; Wang X; Li Y; Wang Y; Ai C
    Proteins; 2011 Apr; 79(4):1154-71. PubMed ID: 21322031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
    Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
    Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes.
    Goto T; Ohta K; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2005 Dec; 13(23):6414-24. PubMed ID: 16099660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
    Goto T; Ohta K; Fujii S; Ohta S; Endo Y
    J Med Chem; 2010 Jul; 53(13):4917-26. PubMed ID: 20521823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.